PT2542268T - Composição sólida para administração oral de corantes e utilização desta - Google Patents

Composição sólida para administração oral de corantes e utilização desta

Info

Publication number
PT2542268T
PT2542268T PT117144097T PT11714409T PT2542268T PT 2542268 T PT2542268 T PT 2542268T PT 117144097 T PT117144097 T PT 117144097T PT 11714409 T PT11714409 T PT 11714409T PT 2542268 T PT2542268 T PT 2542268T
Authority
PT
Portugal
Prior art keywords
colors
oral administration
solid composition
solid
composition
Prior art date
Application number
PT117144097T
Other languages
English (en)
Portuguese (pt)
Inventor
Moro Luigi
Severino Ajani Mauro
Villa Roberto
Celasco Giuseppe
Repici Alessandro
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of PT2542268T publication Critical patent/PT2542268T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041Capsule endoscopes for imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/273Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/31Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003Thiazine dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/006Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089Particulate, powder, adsorbate, bead, sphere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/005Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PT117144097T 2010-03-04 2011-03-02 Composição sólida para administração oral de corantes e utilização desta PT2542268T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A000345A IT1398643B1 (it) 2010-03-04 2010-03-04 Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
US32755710P 2010-04-23 2010-04-23

Publications (1)

Publication Number Publication Date
PT2542268T true PT2542268T (pt) 2016-11-14

Family

ID=42647312

Family Applications (2)

Application Number Title Priority Date Filing Date
PT117144097T PT2542268T (pt) 2010-03-04 2011-03-02 Composição sólida para administração oral de corantes e utilização desta
PT151866829T PT3011975T (pt) 2010-03-04 2011-03-02 Composição sólida para administração oral de corantes e a sua utilização em diagnóstico

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT151866829T PT3011975T (pt) 2010-03-04 2011-03-02 Composição sólida para administração oral de corantes e a sua utilização em diagnóstico

Country Status (26)

Country Link
US (6) US8545811B2 (https=)
EP (2) EP2542268B1 (https=)
JP (1) JP5770752B2 (https=)
KR (1) KR101763700B1 (https=)
CN (1) CN102811747B (https=)
AU (1) AU2011222496B2 (https=)
BR (1) BR112012022373B1 (https=)
CA (1) CA2790143C (https=)
CY (1) CY1123967T1 (https=)
DK (2) DK3011975T3 (https=)
ES (2) ES2602157T3 (https=)
FR (1) FR21C1009I1 (https=)
HR (2) HRP20161366T1 (https=)
HU (3) HUE053977T2 (https=)
IL (1) IL221541A (https=)
IT (1) IT1398643B1 (https=)
LT (2) LT3011975T (https=)
MX (1) MX342323B (https=)
NZ (1) NZ602130A (https=)
PL (2) PL3011975T3 (https=)
PT (2) PT2542268T (https=)
RS (2) RS61641B1 (https=)
RU (1) RU2561034C2 (https=)
SI (1) SI3011975T1 (https=)
WO (1) WO2011107945A1 (https=)
ZA (1) ZA201206360B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP1183014B1 (en) 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
WO2010045477A2 (en) 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP2722058A1 (en) * 2012-10-19 2014-04-23 Cosmo Technologies Ltd Solid oral composition containing dyes for use in endoscopic diagnosis
AU2015212418B2 (en) * 2014-01-29 2020-01-23 Cosmo Technologies Limited Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum
US10124074B2 (en) * 2014-02-26 2018-11-13 Toufic Kachaamy Indirect chromoendoscopy with an oral indigo carmine base preparation
CN106999618A (zh) 2014-12-08 2017-08-01 金诺斯公司 用于颜料消毒的添加剂组合物及其方法
HK1250902A1 (zh) * 2015-04-23 2019-01-18 Obalon Therapeutics, Inc. 用於确定内部装置故障的系统和方法
CN114258912A (zh) 2016-02-12 2022-04-01 金诺斯公司 用于表面净化的组合物和方法
EA201892365A1 (ru) 2016-04-19 2019-03-29 Конарис Рисерч Инститьют Аг Составы и композиции шеллачных микрокапсул
US11185605B2 (en) 2016-07-25 2021-11-30 Kinnos Inc. Device and related compositions and methods for use in surface decontamination
EP3544638A1 (en) 2016-11-28 2019-10-02 Cosmo Technologies Ltd. Solid oral composition containing dyes
FR3059664B1 (fr) 2016-12-01 2019-01-25 Provepharm Life Solutions Procede de preparation du carmin d’indigo
CA3104884A1 (en) 2018-07-12 2020-01-16 Kinnos Inc. Devices, compositions, and methods for use in surface decontamination
CN108888765B (zh) * 2018-07-16 2021-02-26 山东理工大学 一种释放亚甲基蓝聚集体的含亚甲基蓝的二氧化硅/虫胶复合颗粒的制备方法
CN111184876B (zh) * 2020-02-20 2022-03-04 沈伟 一种消化道黏膜染色剂、制备方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
DK0565668T3 (da) * 1991-10-31 2000-01-31 Zila Inc Biologisk farvemiddelsammensætning, fremgangsmåde til fremstilling deraf og til anvendelse til aftegning af epitelcancer
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
EP1183014B1 (en) 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US6584630B1 (en) 2000-04-06 2003-07-01 Ohio Medical Instrument Company, Inc. Radiolucent surgical table extension assembly and method
WO2001076478A1 (en) 2000-04-10 2001-10-18 Nordisk Terapi As System for testing and exercising sensorimotoric control of the neck
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
US7217410B2 (en) 2003-06-17 2007-05-15 The Board Of Trustees Of The Universtiy Of Illinois Surface modified protein microparticles
US20070077202A1 (en) * 2005-06-12 2007-04-05 Pentax Corporation Histostain composition for endoscope
US20070116757A1 (en) * 2005-11-08 2007-05-24 Collegium Pharmaceutical, Inc. Methylene Blue Derivatives

Also Published As

Publication number Publication date
AU2011222496A2 (en) 2012-09-20
US20130058867A1 (en) 2013-03-07
US8545811B2 (en) 2013-10-01
SI3011975T1 (sl) 2021-05-31
RU2012142192A (ru) 2014-04-10
RS61641B1 (sr) 2021-04-29
AU2011222496B2 (en) 2016-08-18
JP5770752B2 (ja) 2015-08-26
EP3011975A1 (en) 2016-04-27
DK2542268T3 (en) 2016-11-28
CN102811747B (zh) 2016-02-24
PL2542268T3 (pl) 2017-05-31
CA2790143A1 (en) 2011-09-09
KR20130015008A (ko) 2013-02-12
MX342323B (es) 2016-09-23
LT3011975T (lt) 2021-04-26
US20130295013A1 (en) 2013-11-07
NZ602130A (en) 2014-07-25
ZA201206360B (en) 2013-10-30
LT2542268T (lt) 2016-12-12
US9402923B2 (en) 2016-08-02
HRP20210493T1 (hr) 2021-05-14
US9402922B2 (en) 2016-08-02
RS55414B1 (sr) 2017-04-28
HRP20161366T1 (hr) 2017-02-24
CA2790143C (en) 2019-01-22
BR112012022373A2 (pt) 2019-11-26
US20130287690A1 (en) 2013-10-31
US10265420B2 (en) 2019-04-23
WO2011107945A1 (en) 2011-09-09
AU2011222496A1 (en) 2012-09-20
BR112012022373B1 (pt) 2021-12-14
MX2012010125A (es) 2013-02-26
IT1398643B1 (it) 2013-03-08
HUE053977T2 (hu) 2021-07-28
EP2542268A1 (en) 2013-01-09
PL3011975T3 (pl) 2021-06-28
CY1123967T1 (el) 2022-05-27
ITMI20100345A1 (it) 2011-09-05
PT3011975T (pt) 2021-03-19
HUS2100005I1 (hu) 2021-03-29
CN102811747A (zh) 2012-12-05
IL221541A (en) 2016-03-31
EP2542268B1 (en) 2016-08-10
US20180214580A1 (en) 2018-08-02
RU2561034C2 (ru) 2015-08-20
US20160184460A1 (en) 2016-06-30
JP2013521271A (ja) 2013-06-10
EP3011975B1 (en) 2021-01-20
KR101763700B1 (ko) 2017-08-01
US20200268909A1 (en) 2020-08-27
FR21C1009I1 (fr) 2021-05-07
DK3011975T3 (da) 2021-03-29
HUE030246T2 (en) 2017-04-28
ES2863986T3 (es) 2021-10-13
ES2602157T3 (es) 2017-02-17

Similar Documents

Publication Publication Date Title
PT2542268T (pt) Composição sólida para administração oral de corantes e utilização desta
BRPI0908292A2 (pt) "métodos e composições para administração oral de exenatida"
BRPI0907077A2 (pt) métodos e composições para administração oral de proteínas
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
LT3222272T (lt) Farmacinė karbetocino kompozicija
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
EP2616076A4 (en) PHARMACEUTICAL COMPOSITIONS
PT2355851T (pt) Novos lípidos e composições para a administração de agentes terapêuticos
IL224976A (en) Converted history of 1h - indazole and a pharmaceutical preparation containing them
EP2643045A4 (en) THERAPEUTIC PROCESSES AND COMPOSITIONS FOR SOLID FORM DELIVERY
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
EP2616053A4 (en) PHARMACEUTICAL COMPOSITIONS FROM CURCUMIN
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0913610A2 (pt) métodos e composições para tratamento bucal
BR112013015085A2 (pt) composição farmacêutica, método para preparar uma composição, e, uso de composição
BRPI1006953A2 (pt) composição farmacêutica, e, uso de uma composição
BRPI0917562A2 (pt) composições farmacêuticas e métodos para estabilizar as mesmas
SMT201500005B (it) Composizione framaceutica inalabile
PT2525827T (pt) Formulações farmacêuticas de loratadina para encapsulação e combinações das mesmas
ZA201108458B (en) Nitrile derivatives and their pharmaceutical use and compositions
BRPI0812000A2 (pt) Métodos e composições para administração de oxibutinina
BR112013006482A2 (pt) composição oral e método de formação e uso da mesma.
PT2571488E (pt) Composição farmacêutica de ibuprofeno para injeção